FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely coagulology, and may be used in treating acute venous thrombosis of various localisations in the clinical conditions accompanied by existing or else threatening hemorrhagic complications. For this purpose, with underlying intake of low-molecular heparins (LMHs) in preventive doses, human Antithrombin III 1000 IU is additionally introduced every three days; total course dose is 5000-10000 IU.
EFFECT: method provides higher clinical effectiveness ensured by intensified antithrombotic potential of LMH with causing no hemorrhagic syndrome aggravations in the patients having both low, and normal endogenic antithrombin III level.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING SUBACUTE VENOUS THROMBOSIS OF VARIOUS LOCALISATIONS | 2015 |
|
RU2595238C1 |
| METHOD FOR ANTICOAGULANT THERAPY AND PREVENTION OF THROMBOTIC COMPLICATIONS IN PATIENTS WITH SEVERE BRAIN DAMAGE IN A CHRONIC CRITICAL CONDITION | 2021 |
|
RU2762945C1 |
| METHOD FOR PREVENTING SEVERE PREGNANCY COMPLICATIONS IN THROMBOPHILIC PATIENTS | 2008 |
|
RU2367446C1 |
| METHOD FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN POST-OPERATIVE PERIOD OF PATIENTS WITH MORBIDITY OBESITY AFTER LAPAROSCOPIC HYSTERECTOMY | 2017 |
|
RU2650975C1 |
| ANTITHROMBOTIC AGENT OF SIBERIAN FIR CELLULOSE | 2014 |
|
RU2571555C1 |
| AGENT WITH ANTICOAGULATING EFFECT AND ITS APPLICATION METHOD | 2021 |
|
RU2799028C2 |
| PERSONALIZED METHOD OF TREATING VEIN THROMBOSIS OF LOWER EXTREMITIES IN WOUNDED | 2023 |
|
RU2813947C1 |
| METHOD FOR EVALUATION OF TREATMENT EFFECTIVENESS IN CARDIAC PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA | 2015 |
|
RU2587752C1 |
| METHOD FOR ASSESSING STATE OF HEMOSTASIS | 2023 |
|
RU2817000C1 |
| METHOD FOR PRESCRIBING INDIVIDUAL ANTITHROMBOTIC THERAPY IN ACUTE AND EARLY PERIODS OF SPINOCRONOUS INJURY OF THE CERVICAL SPINE | 2021 |
|
RU2770633C1 |
